Announcements Trials

Browse Landscape

Phase

Phase 2 2 Phase NA 1 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1 Breast 1

Conditions

Prostatic Neoplasms 502 Urinary Bladder Neoplasms 139 Carcinoma, Renal Cell 116 Neoplasms 66 Kidney Neoplasms 53 Non-Muscle Invasive Bladder Neoplasms 43 Neoplasm Metastasis 38 Carcinoma, Transitional Cell 38 Breast Neoplasms 30 Testicular Neoplasms 28 Recurrence 20 Wilms Tumor 18 Parkinson Disease 4, Autosomal Dominant Lewy Body 14 Pain 13 Ovarian Neoplasms 13 Urologic Neoplasms 12 Testicular Germ Cell Tumor 12 Teratoma 12 Seminoma 12 Multiple Myeloma 12 Burkitt Lymphoma 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Lymphoma, Large B-Cell, Diffuse 11 Carcinoma, Ovarian Epithelial 11 Carcinoma 11 Urogenital Neoplasms 10 Neuroblastoma 10 Lymphoma, Non-Hodgkin 10 Lymphoma, Mantle-Cell 10 Lymphoma, Large-Cell, Immunoblastic 10

Interventions

Tea 1 Sufentanil 1 Morphine 1 Analgesia, Patient-Controlled 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Inflammation × Genitourinary × Clear all

NCT01367418 2012-03-19

AIMS

Örebro University, Sweden

Phase 3 Completed

Inflammation, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡